Neurology News

Researchers at Emory University are developing a visual tool to view how conditions such as Alzheimer's disease and autism spectrum disorder affect the brain in real-time, the university announced in a press release.

A practical risk score tool has been developed to help people identify their potential risk for dementia, researchers reported in JAMA Network Open.

The FDA has extended the Prescription Drug User Fee Act goal date to Dec. 28, for TG Therapeutics’ biologics license application of ublituximab for patients with relapsing forms of MS.

Continuous subcutaneous foslevodopa-foscarbidopa improved motor symptoms and reduced motor fluctuations compared with oral levodopa-carbidopa in patients with advanced Parkinson’s disease, according to a study in The Lancet Neurology.

Kriya Therapeutics Inc. announced the acquisition of biotech company Redpin Therapeutics Inc., bolstering Kriya’s neurology therapeutic portfolio by adding gene therapy programs for epilepsy and trigeminal neuralgia.

A team of researchers at the University of Miami Miller School of Medicine have developed an online platform of metrics designed to assess a patient’s risk for developing Alzheimer’s disease and other neurological issues.

In this edition, neurologic effects of COVID-19 among pediatric populations, FDA accepts NDA for extended-release carbidopa/levodopa, antihistamines could be promising therapy for Parkinson’s disease and more.

The Pershing Square Foundation announced the launch of the Maximizing Innovation in Neuroscience Discover prize to establish a community of multidisciplinary investigators who can improve understanding of the brain and cognition.

BrainCheck Inc. has received a $1.5 million grant award from the Small Business Innovation Research program, which it will use to fund a study of CARE, its digital cognitive care management platform, the company announced in a news release.

Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.